Diploma Thesis from the year 2000 in the subject Business economics - Offline Marketing and Online Marketing, grade: good (2,0), Ruhr-University of Bochum (VWA Lippstadt), language: English, abstract: There is almost no day passing without any news about mergers, acquisitions or cooperations between two or more companies. In most cases, one of the major motivations is the recognition of cost reduction potentials to stabilize profits. Daimler-Benz and Chrysler, since early 1999 known as DaimlerChrysler, merged their R & D and sourcing activities to achieve economies of scale. But for what reason do they have to stabilize profits? Because they live in a world of decreasing margins and stagnating sales. It is evident that despite their high volumes the markets of the industrialized countries are almost satisfied and lack appreciable growth rates. Product life cycles (PLCs) become gradually shorter, reducing the profit periods of products. Moreover, these markets are mostly dominated by a destructive price competition so that often companies are forced to offer at almost dumping prices in order to survive. The big German mineral oil enterprises recently claimed that the introduction of Dea′s payback card to bind their customers via a one-pfennig (!) patronage refund per consumed liter had been, in their opinion, responsible for a follow-up ruinous price "battle". At the same time, they were all fighting together against the private brands. Shortly afterwards, it was the food trade battling, which had been instigated by Wal Mart′s dumping-price policy with basic foodstuff. And this development will continue. Therefore, companies more and more initiate activities to conquer foreign markets, with many of them evading to less developed countries. This apparent contradiction turns out to be a logical step of enlarging upon business activities because many of these countries are on the threshold of becoming industrialized and consequently, they reveal huge potentials of unsatisfied demands, which, up to that point, remained unattended. Hence, even small and medium-sized enterprises turn "international", seeking advantages in distribution and sourcing as well.

Inside the Minds: Biotechnology Deals is an authoritative, insider's perspective on the issues surrounding biotech deals, including mergers and acquisitions, collaborations, and the future of doing successful deals. Featuring lawyers, CEOs of funded biotech companies, and venture capitalists who invest in them, this book provides a broad, yet comprehensive overview of the art of doing successful deals from the experts themselves. From finding and capitalizing on opportunities to completing the deal, these authors articulate the finer points around doing biotech deals now and what will hold true into the future. The different niches represented and the breadth of perspectives presented enable readers to get inside some of the great legal minds of today as experts offer up their thoughts around the keys to success within this fascinating area.About Inside the Minds:Inside the Minds provides readers with proven business intelligence from C-Level executives (Chairman, CEO, CFO, CMO, Partner) from the world's most respected companies nationwide, rather than third-party accounts from unknown authors and analysts. Each chapter is comparable to an essay/thought leadership piece and is a future-oriented look at where an industry, profession or topic is headed and the most important issues for the future. Through an exhaustive selection process, each author was hand-picked by the Inside the Minds editorial board to author a chapter for this book.This book is by: Lee R. Brettman, M.D., FACP, Dynogen Pharmaceuticals, Inc.??Successful Strategies for Biotech Deals?Manish N Chapekar, Montreux Equity Partners??Building Successful Biotech Deals?Daniel Devine, Acceptys, Inc.??The Art of the Deal?Mark I. Gruhin, Schmeltzer, Aptaker & Shepard, PC??Mergers and Acquisitions, Collaborations, and Partnerships?James T. Gunton, NJTC Venture Fund??Strategies for Successful Deals?Johnny Humphreys, Gen Prime??Finding Success in Biotech?Roland H. Johnson, Piedmont Pharmaceuticals LLC??Making Your Way Through Biotech Dealings?Thomas G. Klopack, Self Employed, Former CEO of Aclara Biosciences??Keys to Success in Biotechnology?Gerard J. McGarrity, Ph.D., Intronn Inc.??Successful Biotech Deals?Mark Schwartz , Ph.D., Bayhill Therapeutics??Biotech Deal Strategies?Abhi-Shek Jain, WTP Capital, LLC??Secrets to Success?Alexis V. Lukianov, NuVasive, Inc.??Finding and Capitalizing on Opportunities?

This set includes articles from the four main fields which have influenced the study of Mergers and Acquisitions: Economics, Finance, Strategic Management and Human Resource Management. Featuring the key papers by individuals who shaped the field, the collection presents these formative pieces in thematically grouped sections, including coverage of: * Perspectives on the modern business corporation and the role of mergers and acquisitions: historical, financial, strategic and management * Causes of mergers and acquisitions activity * Performance impact of mergers and acquisitions activity * Public policy and the corporation The set features a comprehensive index and original introductory material.

Mergers and Acquisitions: Text and Cases provides guiding frameworks and information on Mergers and Acquisitions (M&A), complemented by a set of well-matched cases. The purpose is not to rehash the existing set of M&A books, but to provide real-world examples of situations that allow the reader to utilize the core concepts and processes in M&A. The authors present a process-based framework of M&A, within which the reader is given in-depth information about the steps in doing deals. The reader then has the ability to apply these concepts and frameworks to the full-length cases. The book can be used as a stand-alone text because it provides good coverage of the entire M&A process. In order to more specifically focus on any particular aspect of M&A, the text can easily be supplemented with focused materials.

"By assembling the highly focused works of more than two dozen businessmen, lawyers, accountants, investment bankers, consultants, and experts in such fields as risk management and human resources, BenDaniel and Rosenbloom seamlessly illuminate a complex subject."-Paul E. Graf, President and CEO, Axel Johnson Inc. This fully revised Second Edition shows readers how to find, analyze, structure, and negotiate international deals.